 Background: Clinical drawbacks of beta-blocker treatment in stable angina have motivated researchers to provide alternative heart rat lowering agents, such as tedisamil which additionally exerts antiischemic and antiarrhythmic effects by blockade of cellular repolarizing K+ currents.  
